Oral hormone replacement therapy: factors that influence the estradiol concentrations achieved in a multiracial study population.
- 1 February 2002
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 42 (2) , 137-144
- https://doi.org/10.1177/00912700222011166
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Associations between Low Levels of Serum Estradiol, Bone Density, and Fractures among Elderly Women: The Study of Osteoporotic FracturesJournal of Clinical Endocrinology & Metabolism, 1998
- Low-Dose Esterified Estrogen TherapyArchives of internal medicine (1960), 1997
- Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center studyJournal of Clinical Endocrinology & Metabolism, 1996
- A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1992
- Transdermal Estradiol With Oral Progestin: Biological and Clinical Effects in Younger and Older Postmenopausal WomenJournal of Gerontology, 1991
- COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMENClinical Endocrinology, 1989
- Generic Drugs: Bioequivalence and BioavailabilityPublished by American Medical Association (AMA) ,1988
- Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.BMJ, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986